Peter Devine - Profile and Investment Details

Investor Profile

Peter Devine is a Micro VC, Venture Capital, Private Equity Firm based in Brisbane, Queensland, Australia with a diverse investment portfolio that includes companies such as QUE Oncology, Smart Sparrow, TenasiTech, Spinifex Pharmaceuticals, Manjrasoft, PERKii, Hatchtech, Brisbane Materials Technology, Q-Sera, Ena Respiratory, OPAL Therapeutics, Fultec Semiconductor, Pepfactants, Hydrexia, Morse Micro, Otifex, Exonate, Nexgen Plants Pty Limited, ProGel, Forcite Helmet Systems, MetaBloQ, Cardihab, Kinoxis Therapeutics, OccuRx, BT Imaging, QRxPharma, Agerris, Wildlife Drones, Fibrotech Therapeutics. Over time, Peter Devine has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Peter Devine is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Semiconductor, Medical Testing, Family Services, Transportation, Energy, Solar, Artificial Intelligence (AI), Robotics, Product Design, Information Technology (IT), Electronics, Biotech, Internet of Things (IoT), Mobile, Software, Manufacturing, Healthcare, Biotechnology, Market Research, Productivity Software, Search Engine, Agriculture, Health Diagnostics, Farming, Drones, Renewable Energy, Medical, Therapeutics, Media and Entertainment, Machine Learning, Biopharma, Wireless may find it worthwhile to explore potential connections with Peter Devine, as their portfolio suggests a familiarity and interest in this area.

Understanding Peter Devine’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.